+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Severe Acute Respiratory Syndrome"

COVID-19 Saliva Screening Test Potential Market Report 2025 - Product Thumbnail Image

COVID-19 Saliva Screening Test Potential Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Multiplexed Diagnostics Market - Global Strategic Business Report - Product Thumbnail Image

Multiplexed Diagnostics Market - Global Strategic Business Report

  • Report
  • February 2026
  • 382 Pages
  • Global
From
From
From
COVID-19 Testing - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Testing - Global Strategic Business Report

  • Report
  • February 2026
  • 1417 Pages
  • Global
From
From
In Vitro Lung Model - Global Strategic Business Report - Product Thumbnail Image

In Vitro Lung Model - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
In Vitro Diagnostics - Global Strategic Business Report - Product Thumbnail Image

In Vitro Diagnostics - Global Strategic Business Report

  • Report
  • February 2026
  • 181 Pages
  • Global
From
From
From
From
Loading Indicator

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses. Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution. Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more